実績

Publications

【取りまとめ2020】Tibial Tubercle–Midepicondyle Distance Can Be a Better Index to Predict the Outcome of Medial Patellofemoral Ligament Reconstruction Than Tibial Tubercle-Trochlear Groove Distance.(原著論文等 (英文))

  • 2020年

    Iseki T, Nakayama H, Daimon T, Kambara S, Kanto R, Yamaguchi M, Onishi S, Tachibana T, Yoshiya S. Tibial tubercle–midepicondyle distance can be a better index to predict the outcome of medial patellofemoral ligament reconstruction than tibial tubercle-trochlear groove distance. Arthrosc Sports Med Rehabil. 2020 Dec;2(6):e697-e704. doi: 10.1016/j.asmr.2020.04.014.

    Wakabayashi I, Eguchi R, Sotoda Y, von Lewinski D, Sourij H, Daimon T, Groschner K, Rainer PP. Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study. Sci Rep. 2020 Aug 12;10(1):13628. doi: 10.1038/s41598-020-69332-0.

    Sugita S, Mandai M, Hirami Y, Takagi S, Maeda T, Fujihara M, Matsuzaki M, Yamamoto M,  Iseki K, Hayashi N, Hono A, Fujino S, Koide N, Sakai N, Shibata Y, Terada M, Nishida M, Dohi H, Nomura M, Amano N, Sakaguchi H, Hara C, Maruyama K, Daimon T, Igeta M, Oda T,  Shirono U, Tozaki M, Totani K, Sugiyama S, Nishida K, Kurimoto Y, Takahashi M. HLA-matched allogeneic iPS cells-derived RPE transplantation for macular degeneration. J Clin Med. 2020 Jul 13;9(7):2217. doi: 10.3390/jcm9072217.

    Saito S, Toda K, Miyagawa S, Yoshikawa Y, Hata H, Yoshioka D, Sera F, Nakamoto K, Daimon T, Sakata Y, Sawa Y. Recovery from exhaustion of the Frank-Starling mechanism by mechanical unloading with a continuous-flow ventricular assist device. Circ J. 2020 Jun 25;84(7):1124-1131. doi: 10.1253/circj.CJ-20-0070. 

    Saito S, Toda K, Miyagawa S, Yoshikawa Y, Hata H, Yoshioka D, Sera F, Nakamoto K, Daimon T, Sakata Y, Sawa Y. Recovery from exhaustion of the Frank-Starling mechanism by mechanical unloading with a continuous-flow ventricular assist device. Circ J. 2020 Jun 25;84(7):1124-1131. doi: 10.1253/circj.CJ-20-0070. 

    Shiga T, Ikeda T, Shimizu W, Kinugawa K, Sakamoto A, Nagai R, Daimon T, Oki K, Okamoto H, Yamashita T. Efficacy and safety of landiolol in patients with ventricular tachyarrhythmias with or without renal impairment – Subanalysis of the J-Land II study. Circ Rep. 2020 Jun 20;2(8):440-445. doi: 10.1253/circrep.CR-20-0017.

    Homma, G., & Daimon, T. (2020). Sample size calculation for “gold-standard” noninferiority trials with fixed margins and negative binomial endpoints. Stat Biopharm Res. 13(4), 435–447. https://doi.org/10.1080/19466315.2020.1766551

    Nishi M, Kimura T, Igeta M, Furuta M, Suenaga K, Matsumura T, Fujimura H, Jinnai K, Yoshikawa H. Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients. PLoS One. 2020 May 14;15(5):e0224912. doi: 10.1371/journal.pone.0224912.

    Igeta M. and Matsui S. Incorporating follow-up lengths in sample size re-estimation to compare over-dispersed count data, 41st Annual Conference of the International Society for Clinical Biostatistics, Kraków, Poland, 23-27 August 2020.

    Homma G, Daimon T. Sequential parallel comparison design with two coprimary endpoints. Pharm Stat. 2020 May;19(3):243-254. doi: 10.1002/pst.1987.

    Takahashi K, Yamamoto K. A non-inferiority test and sample size determination for comparing two predictive values of diagnostic tests. Commun. Stat. Case Stud. Data Anal. Appl. 2020 Apr;6(2):109-122. doi: 10.1080/23737484.2020.1719559. 

    Fujikawa K, Teramukai S, Yokota I, Daimon T. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability. Biom J. 2020 Mar;62(2):330-338. doi: 10.1002/bimj.201800404.

    Kakizume T, Zhang F, Kawasaki Y, Daimon T. Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpoints. Pharm Stat. 2020 Jan;19(1):71-83. doi: 10.1002/pst.1971.

    Takahashi K, Yamamoto K. An exact test for comparing two predictive values in small-size clinical trials. Pharm Stat. 2020 Jan;19(1):31-43. doi: 10.1002/pst.1968. 

実績一覧にもどる